Literature DB >> 9261824

Association between a delta opioid receptor gene polymorphism and heroin dependence in man.

P Mayer1, H Rochlitz, E Rauch, H Rommelspacher, H E Hasse, S Schmidt, V Höllt.   

Abstract

Two allelic variants of the delta opioid receptor gene, distinguished by a single base exchange T to C in codon 307 of the translated region, were detected in humans. The amino acid sequence was thereby not changed. The resulting C and T alleles combined to give the three genotypes CC, CT and TT. Allele C was more frequent in a sample of 103 German Caucasian heroin addicts (53.4%) than in a control group (39.1%, n = 115). The proportion of CC homozygotes was much greater among the drug-dependent subjects (26.2%) than in controls (9.6%). Although the reasons for this association remain to be explained, our results argue for a participation of the delta type of opioid receptors in the pathophysiology of heroin dependence.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9261824     DOI: 10.1097/00001756-199707280-00025

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  32 in total

Review 1.  Genetic studies of alcoholism and substance dependence.

Authors:  T Reich; A Hinrichs; R Culverhouse; L Bierut
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

Review 2.  Genetic variations in human G protein-coupled receptors: implications for drug therapy.

Authors:  W Sadee; E Hoeg; J Lucas; D Wang
Journal:  AAPS PharmSci       Date:  2001

3.  Searching for evidence of genetic mediation of opioid withdrawal by opioid receptor gene polymorphisms.

Authors:  Jermaine D Jones; Rachel R Luba; Jonathan L Vogelman; Sandra D Comer
Journal:  Am J Addict       Date:  2015-12-21

Review 4.  An overview of the genetics of substance use disorders.

Authors:  H M Lachman
Journal:  Curr Psychiatry Rep       Date:  2006-04       Impact factor: 5.285

5.  The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk.

Authors:  H Zhang; H R Kranzler; B-Z Yang; X Luo; J Gelernter
Journal:  Mol Psychiatry       Date:  2007-07-10       Impact factor: 15.992

Review 6.  A review of pharmacogenetic studies of substance-related disorders.

Authors:  Jermaine D Jones; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2015-03-18       Impact factor: 4.492

Review 7.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

Review 8.  The genetic mediation of individual differences in sensitivity to pain and its inhibition.

Authors:  J S Mogil
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

9.  An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans.

Authors:  Richard C Crist; Toni-Kim Clarke; Alfonso Ang; Lisa M Ambrose-Lanci; Falk W Lohoff; Andrew J Saxon; Walter Ling; Maureen P Hillhouse; R Douglas Bruce; George Woody; Wade H Berrettini
Journal:  Neuropsychopharmacology       Date:  2013-04-23       Impact factor: 7.853

10.  Functional impact of a single-nucleotide polymorphism in the OPRD1 promoter region.

Authors:  Huiping Zhang; Joel Gelernter; Jeffrey R Gruen; Henry R Kranzler; Aryeh I Herman; Arthur A Simen
Journal:  J Hum Genet       Date:  2010-03-19       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.